145 related articles for article (PubMed ID: 15598573)
21. Stearic acid protects primary cultured cortical neurons against oxidative stress.
Wang ZJ; Liang CL; Li GM; Yu CY; Yin M
Acta Pharmacol Sin; 2007 Mar; 28(3):315-26. PubMed ID: 17302992
[TBL] [Abstract][Full Text] [Related]
22. Four new neuroprotective dihydropyranocoumarins from Angelica gigas.
Kang SY; Lee KY; Sung SH; Kim YC
J Nat Prod; 2005 Jan; 68(1):56-9. PubMed ID: 15679317
[TBL] [Abstract][Full Text] [Related]
23. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.
Sizonenko SV; Sirimanne ES; Williams CE; Gluckman PD
Brain Res; 2001 Dec; 922(1):42-50. PubMed ID: 11730700
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake.
Colleoni S; Jensen AA; Landucci E; Fumagalli E; Conti P; Pinto A; De Amici M; Pellegrini-Giampietro DE; De Micheli C; Mennini T; Gobbi M
J Pharmacol Exp Ther; 2008 Aug; 326(2):646-56. PubMed ID: 18451317
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of Esaprazole analogues showing σ1 binding and neuroprotective properties in vitro.
Kelly NM; Wellejus A; Elbrønd-Bek H; Weidner MS; Jørgensen SH
Bioorg Med Chem; 2013 Jun; 21(11):3334-47. PubMed ID: 23601816
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
Conti P; De Amici M; Grazioso G; Roda G; Pinto A; Hansen KB; Nielsen B; Madsen U; Bräuner-Osborne H; Egebjerg J; Vestri V; Pellegrini-Giampietro DE; Sibille P; Acher FC; De Micheli C
J Med Chem; 2005 Oct; 48(20):6315-25. PubMed ID: 16190758
[TBL] [Abstract][Full Text] [Related]
29. [Pretective action of peptide pro-gly-pro on electrophysiological characteristics of cultured hippocampal neurones during excitotoxic damage].
Maslov VIu; Veselovs'kyĭ MS; Moskaliuk AO; M"iasoiedov MF; Shram SI; Fedulova SA
Fiziol Zh (1994); 2014; 60(2):3-11. PubMed ID: 25007514
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis and neuroprotective activity in cell culture of aminoadamantane analogues].
Li YP; Li ZR; Cao J; Tao YJ
Yao Xue Xue Bao; 2007 Apr; 42(4):392-5. PubMed ID: 17633206
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of steroid analogues on P19-N neurons.
Xilouri M; Avlonitis N; Calogeropoulou T; Papazafiri P
Neurochem Int; 2007 Mar; 50(4):660-70. PubMed ID: 17316905
[TBL] [Abstract][Full Text] [Related]
32. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
Guan J; Gluckman PD
Br J Pharmacol; 2009 Jul; 157(6):881-91. PubMed ID: 19438508
[TBL] [Abstract][Full Text] [Related]
33. Selenium compounds counteract the stimulation of ecto-nucleotidase activities in rat cultured cerebellar granule cells: putative correlation with neuroprotective effects.
Ghisleni G; Porciúncula LO; Mioranzza S; Boeck CR; Rocha JB; Souza DO
Brain Res; 2008 Jul; 1221():134-40. PubMed ID: 18554575
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons.
González JC; Egea J; Del Carmen Godino M; Fernandez-Gomez FJ; Sánchez-Prieto J; Gandía L; García AG; Jordán J; Hernández-Guijo JM
Eur J Neurosci; 2007 Nov; 26(9):2481-95. PubMed ID: 17986028
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant activity and neuroprotective effects of zolpidem and several synthesis intermediates.
García-Santos G; Herrera F; Martín V; Rodriguez-Blanco J; Antolín I; Fernández-Marí F; Rodriguez C
Free Radic Res; 2004 Dec; 38(12):1289-99. PubMed ID: 15763953
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents.
Marinelli L; Fornasari E; Di Stefano A; Turkez H; Genovese S; Epifano F; Di Biase G; Costantini E; D'Angelo C; Reale M; Cacciatore I
Bioorg Med Chem Lett; 2019 Jan; 29(2):194-198. PubMed ID: 30522955
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel neuroprotective 1,2-dithiolane/chroman hybrids.
Koufaki M; Kiziridi C; Alexi X; Alexis MN
Bioorg Med Chem; 2009 Sep; 17(17):6432-41. PubMed ID: 19647438
[TBL] [Abstract][Full Text] [Related]
38. Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.
Kang SY; Kim YC
J Pharm Pharmacol; 2007 Jun; 59(6):863-70. PubMed ID: 17637179
[TBL] [Abstract][Full Text] [Related]
39. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity.
Kumar DM; Perez E; Cai ZY; Aoun P; Brun-Zinkernagel AM; Covey DF; Simpkins JW; Agarwal N
Free Radic Biol Med; 2005 May; 38(9):1152-63. PubMed ID: 15808412
[TBL] [Abstract][Full Text] [Related]
40. Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535.
Galluzzo M; Pintor A; Pèzzola A; Grieco R; Borsini F; Popoli P
Eur J Pharmacol; 2008 Jan; 579(1-3):149-52. PubMed ID: 18036583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
